XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. is a blank check company organized to pursue a merger or acquisition target within the pharmaceutical and life sciences sector. The company filed a Form 10-K with the Securities and Exchange Commission on March 5, 2019, covering fiscal year 2018, consistent with a blank check vehicle that completed its initial public offering in 2018. Registered under SEC CIK 0001697805, the vehicle was structured as a traditional SPAC seeking an operating pharmaceutical business candidate. Sponsor details and current deal status are on file with the SEC. Researchers and investors seeking full SPAC analytics, sponsor profiles, and real-time deal tracking can sign up for complete data access at SpacDesk.